REVOLUTION MEDICINES INC (RVMD) Stock Earnings & Estimates
USA - NASDAQ:RVMD - US76155X1000 - Common Stock
46.58 USD
-0.13 (-0.28%)
46.4187 USD
-0.16 (-0.35%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.39M -31.62% | 35.38M 20.38% | 11.58M -67.27% | 306K -100.00% | 4.31M | 24.245M 462.53% | 153.57M 533.41% | 670.89M 336.86% | 1.525B 127.31% | 2.713B 77.90% | 4.024B 48.32% | 4.876B 21.17% | |
| EBITDA YoY % growth | -183.86M -71.80% | -253.24M -37.74% | -481.075M -89.97% | -673.512M -41.74% | -1.065B -56.18% | -1.21B -13.62% | -1.299B -7.38% | -1.107B 14.84% | -578.279M 47.74% | 521.19M 190.13% | 1.596B 206.22% | 2.198B 37.72% | |
| EBIT YoY % growth | -188.01M -69.84% | -258.28M -37.38% | -487.185M -88.63% | -680.641M -41.53% | -1.103B -59.90% | -1.196B -8.46% | -1.082B 9.55% | -571.168M 47.20% | 165.16M 128.92% | 1.071B 548.46% | 2.143B 100.09% | 2.588B 20.77% | |
| Operating Margin | -639.71% | -730.02% | -4,207.12% | -222,431.83% | -25,580.60% | -4,932.27% | -704.35% | -85.14% | 10.83% | 39.48% | 53.26% | 53.08% | |
| EPS YoY % growth | -2.56 -19.63% | -3.10 -21.09% | -3.77 -21.71% | -3.54 5.38% | -5.41 -51.65% | -6.02 -11.14% | -5.85 2.79% | -2.90 50.35% | 1.16 139.92% | 5.65 387.73% | 9.62 70.09% | 10.98 14.16% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.45 -54.28% | -1.56 -39.39% | -1.50 -32.56% | -1.58 -20.80% | -1.53 -5.50% | -1.44 7.75% |
| Revenue Q2Q % growth | 1.985M | 1.985M | -100.00% | -100.00% | ||
| EBITDA Q2Q % growth | -289.264M -72.93% | -310.017M -48.56% | -216.24M 6.90% | -217.26M 12.72% | -218.28M 24.54% | -219.3M 29.26% |
| EBIT Q2Q % growth | -287.507M -63.62% | -307.662M -42.23% | -299.519M -35.96% | -314.951M -31.44% | -297.819M -3.59% | -301.49M 2.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.31 -61.73% | -1.16 | -0.15 | -12.79% |
| Q1 2025 Q2Q % growth | -1.13 -61.43% | -1.11 | -0.02 | -1.54% |
| Q4 2024 Q2Q % growth | -1.12 1.75% | -1.01 | -0.11 | -11.25% |
| Q3 2024 Q2Q % growth | -0.94 5.34% | -0.91 | -0.03 | -3.17% |
| Q2 2024 Q2Q % growth | -0.81 11.96% | -0.79 | -0.02 | -2.48% |
| Q1 2024 Q2Q % growth | -0.70 2.78% | -0.76 | 0.06 | 8.02% |
| Q4 2023 Q2Q % growth | -1.14 -80.95% | -0.90 | -0.24 | -26.70% |
| Q3 2023 Q2Q % growth | -0.99 -14.14% | -1.03 | 0.03 | 3.23% |
| Q2 2023 Q2Q % growth | -0.92 -12.20% | -0.84 | -0.08 | -9.49% |
| Q1 2023 Q2Q % growth | -0.72 7.69% | -0.83 | 0.11 | 13.23% |
| Q4 2022 Q2Q % growth | -0.63 11.27% | -0.84 | 0.21 | 24.84% |
| Q3 2022 Q2Q % growth | -0.87 -20.83% | -0.86 | -0.01 | -1.27% |
| Q2 2022 Q2Q % growth | -0.82 -36.67% | -0.87 | 0.05 | 5.39% |
| Q1 2022 Q2Q % growth | -0.78 -47.17% | -0.79 | 0.01 | 1.31% |
| Q4 2021 Q2Q % growth | -0.71 -36.54% | -0.65 | -0.06 | -9.01% |
| Q3 2021 Q2Q % growth | -0.72 -71.43% | -0.64 | -0.08 | -12.86% |
| Q2 2021 Q2Q % growth | -0.60 -30.43% | -0.57 | -0.03 | -5.04% |
| Q1 2021 Q2Q % growth | -0.53 28.38% | -0.53 | 0.00 | 0.84% |
| Q4 2020 Q2Q % growth | -0.52 92.02% | -0.39 | -0.13 | -32.76% |
| Q3 2020 Q2Q % growth | -0.42 | -0.40 | -0.02 | -5.04% |
| Q2 2020 Q2Q % growth | -0.46 | -0.37 | -0.09 | -24.58% |
| Q1 2020 Q2Q % growth | -0.74 | -0.34 | -0.40 | -118.19% |
| Q4 2019 Q2Q % growth | -6.52 | -0.42 | -6.10 | -1,459.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.867M | -2.867M | -100.00% | |
| Q4 2024 Q2Q % growth | -100.00% | 353.073K | -353.073K | -100.00% |
| Q3 2024 Q2Q % growth | 327.859K | -327.859K | -100.00% | |
| Q2 2024 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 1.404M | -1.404M | -100.00% |
| Q4 2023 Q2Q % growth | 742K -95.16% | 1.113M | -371K | -33.33% |
| Q3 2023 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2023 Q2Q % growth | 3.824M -58.07% | 1.594M | 2.23M | 139.90% |
| Q1 2023 Q2Q % growth | 7.014M -7.47% | 2.996M | 4.018M | 134.11% |
| Q4 2022 Q2Q % growth | 15.33M 62.05% | 7.908M | 7.422M | 93.85% |
| Q3 2022 Q2Q % growth | 3.36M 205.45% | 6.406M | -3.046M | -47.55% |
| Q2 2022 Q2Q % growth | 9.12M 4.83% | 7.159M | 1.961M | 27.39% |
| Q1 2022 Q2Q % growth | 7.58M -25.17% | 8.67M | -1.09M | -12.57% |
| Q4 2021 Q2Q % growth | 9.46M 8.11% | 9.096M | 364K | 4.00% |
| Q3 2021 Q2Q % growth | 1.1M -91.31% | 8.874M | -7.774M | -87.60% |
| Q2 2021 Q2Q % growth | 8.7M -13.26% | 9.571M | -871K | -9.10% |
| Q1 2021 Q2Q % growth | 10.13M -12.29% | 9.649M | 481K | 4.98% |
| Q4 2020 Q2Q % growth | 8.75M -27.63% | 17.116M | -8.366M | -48.88% |
| Q3 2020 Q2Q % growth | 12.66M 1.20% | 14.525M | -1.865M | -12.84% |
| Q2 2020 Q2Q % growth | 10.03M -18.32% | 13.627M | -3.597M | -26.40% |
| Q1 2020 Q2Q % growth | 11.55M -12.30% | 13.643M | -2.093M | -15.34% |
| Q4 2019 Q2Q % growth | 12.09M | 13.107M | -1.017M | -7.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -1.33% | -12.54% |
| Revenue | N/A | N/A | -33.32% | 213% |